EIT Health

GE Healthcare, as a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.

E-Group is an SME established in 1993, having CEE regional reach with existing client base and international experience in Asia and the US as well. E-Group has a strong product portfolio and expertise in: - user identification, authentication, ID management, tokenization, integrity protection, digital signature, encryption and privacy aspects of data access; - designing and operating mission critical systems (transactional clearing and settlement, payment systems, data collection and distribution) for the financial sector, the national energy grid and energy market operators and the Government. - smart mobile communication technology for integrated video/voice/chat/file based conversation with integrated speech2text, text2speech, language processing, semantic interpretation and intelligent dialog management capabilities and other applied Artificial Intelligence solutions (in cooperation with leading global AI platform partners).

CRU has been providing clinical research services to the pharmaceutical industry for over a decade and basic research services since 2015. CRU sites are located in Hungary, Ukraine, Germany, Vietnam and LAO PDR. CRU activities: - Clinical Research: from Phase I to Phase IV, inpatient and outpatient services, Investigator Initiated Trials (IITs) - Basic Research: Pre-Clinical, Biomarker research, Pulmonary Diseases, Neurodegenerative diseases, Bioinformatics - Own drug development: against dementia - Biobanking: disease-specific biobank for research purposes - E-Health Informatics: software development, AAL projects - Healthcare Diagnostics: Radiology, and Molecular Biology services for research and treatment purposes - Managed Care in Oncology: precision medicine, medical tourism - Education projects: from primary school to post doctoral programs - Hospital Investment projects: EU and South-East Asia

Bluepharma is a Portuguese capital pharmaceutical company, based in Coimbra. The Bluepharma Group is today one of the most entrepreneurial and innovative in the pharmaceutical sector, having already achieved a remarkable prestige not only in Portugal, but also in the most demanding international markets. Bluepharma concentrates its efforts on the manufacturing, development and marketing of pharmaceutical drugs. With over 30 years of experience in producing pharmaceutical products, we guarantee standards of the highest quality, based on the know-how of our technical staff, and vision and dynamism of our management team. Bluepharma's activities are carried out in 3 distinct areas: Research, development and registration of pharmaceutical drugs; Producing pharmaceutical drugs for Bluepharma and other companies; Marketing of generic pharmaceuticals.

Celon Pharma Inc. is an integrated biopharmaceutical company dedicated to the research, development, production, and sales and marketing of pharmaceutical products. The company has its own R&D laboratories consisting of Organic Synthesis Laboratory, Laboratory Methods of Pharmaceutical Control Laboratory and Quality Assurance and Research and Development Laboratory of Biotechnology Medicines, allowing it to develop their own innovative pharmaceutical technologies utilization of available laboratory facilities and hardware, as well as experience staff involved scientists. Celon Pharma Department of Research and Development for Innovative Medicines include: Laboratory of Medical Chemistry, Oligonucleotide Synthesis, Molecular Biology and Cell Culture Laboratory, as well as unique in the country's private NMR Laboratory. The Company has the necessary facilities to carry out research into innovative medicines. We are very acitve in validating the therapeutic suitability of chemical molecules using biochemical, physiological and molecular biology methods. The company has a modern manufacturing facility, which produces dry pharmaceutical forms. In recent years, the company has launched products in the following therapeutic areas: oncology (medicine Aromek ® - breast cancer), diseases of the nervous system: (a drug Donepex ® - Alzheimer's disease, drugs: Ketrel ®, Olasyn ® and Candela ® - schizophrenia) heart disease (drugs Valzek ®, Grepid ®, Cilapril ®) and HIV treatment (drug Lazivir ®). Celon Pharma as part of an innovative research and development activities currently employs 60 professionals with training in the field of medicinal chemistry, biology, biotechnology and pharmaceuticals.